Cossu Fausto, Vulliamy Tom J, Marrone Anna, Badiali Manuela, Cao Antonio, Dokal Inderjeet
Bone Marrow Transplant Unit, Ospedale Microcitemico, Cagliari, Italy.
Br J Haematol. 2002 Dec;119(3):765-8. doi: 10.1046/j.1365-2141.2002.03822.x.
X-linked Hoyeraal-Hreidarsson syndrome (XL-HHS) is the severe infantile variant of X-linked dyskeratosis congenita (XL-DC) and both are due to mutations in the DKC1 gene within Xq28. We report a novel missense mutation in DKC1 exon 3 (T113-->C, Ile38Thr) in a Sardinian infant with XL-HHS in whom the disease was characterized by 'T+B-NK-' severe combined immunodeficiency and bone marrow failure. He underwent sibling bone marrow transplantation using a conditioning regimen (fludarabine, rabbit antithymocyte globulin, low-dose melphalan) selected according to the HHS/DC phenotype. This was associated with low toxicity, prompt engraftment with adequate immune reconstitution and full donor haemopoiesis.
X连锁Hoyeraal-Hreidarsson综合征(XL-HHS)是X连锁先天性角化不良(XL-DC)的严重婴儿型,两者均由Xq28区域内的DKC1基因突变所致。我们报告了一名患有XL-HHS的撒丁岛婴儿中DKC1外显子3的一个新的错义突变(T113→C,Ile38Thr),该患儿的疾病特征为“T+B-NK-”严重联合免疫缺陷和骨髓衰竭。他接受了同胞骨髓移植,采用了根据HHS/DC表型选择的预处理方案(氟达拉滨、兔抗胸腺细胞球蛋白、低剂量美法仑)。这与低毒性、快速植入以及充分的免疫重建和完全的供体造血有关。